Ziprasidone monotherapy in bipolar II depression: an open trial.
暂无分享,去创建一个
M. Liebowitz | D. Dunner | Rajiv Pratap | E. Salmán | J. Akhtar | A. Mech | A. E. Johnson
[1] T. Suppes,et al. Bipolar II disorder: arguments for and against a distinct diagnostic entity. , 2008, Bipolar Disorders.
[2] M. Thase,et al. Aripiprazole Monotherapy in Nonpsychotic Bipolar I Depression: Results of 2 Randomized, Placebo-Controlled Studies , 2008, Journal of clinical psychopharmacology.
[3] David J Miklowitz,et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. , 2007, The New England journal of medicine.
[4] Franco Benazzi,et al. Bipolar disorder—focus on bipolar II disorder and mixed depression , 2007, The Lancet.
[5] J. Calabrese,et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. , 2005, The American journal of psychiatry.
[6] S. Kapur,et al. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone. , 2004, The American journal of psychiatry.
[7] J. Calabrese,et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. , 2003, Archives of general psychiatry.
[8] H. Möller,et al. Recent advances in the treatment of bipolar depression , 2007 .
[9] J. Ballenger. A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression , 2007 .
[10] L. Scott,et al. Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder. , 2006, CNS drugs.